About amanda diffenderfer

This author has not yet filled in any details.
So far amanda diffenderfer has created 10 blog entries.

AADE Conference August 16-20th, 2018

By |2018-08-09T17:09:40+00:00August 9th, 2018|Uncategorized|

Join Eversense at the Annual AADE Conference, August 16-20th, 2018 in Baltimore, MD! We will have two exhibit locations, booth #811 and #465. Booth #811 will feature the Eversense CGM System, procedure demonstration, a fantastic line up of booth theater presentations (see the schedule below) and an introduction to Glo, our brand ambassador, and [...]

FDA Approves World’s First Long-Term Implantable Continuous Glucose Monitoring System for Marketing in United States

By |2018-06-21T15:22:25+00:00June 21st, 2018|Uncategorized|

FDA Approves World’s First Long-Term Implantable Continuous Glucose Monitoring System for Marketing in United States GERMANTOWN, Md., June 21, 2018 — Senseonics Holdings, Inc. (NYSE American: SENS) today announced the U.S. Food and Drug Administration has approved its Pre-market Approval (PMA) application to market the company’s Eversense® Continuous Glucose Monitoring (CGM) System to people with diabetes [...]

Senseonics Announces Favorable Outcome of FDA Advisory Committee on the Eversense System

By |2018-06-21T14:59:24+00:00April 2nd, 2018|CGM, Senseonics|

GERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of Eversense®, a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced a favorable outcome of the U.S. Food and Drug Administration (FDA) Clinical Chemistry and Clinical Toxicology Devices meeting on the Eversense system. [...]

Webinar: Senseonics Science & Education Series

By |2017-12-04T17:05:55+00:00November 27th, 2017|Science & Technology, Senseonics|

You are invited to  the first webinar in the Senseonics Science & Education Series presented by Director of Engineering, Dr. Andrew (Andy) DeHennis on Fluorescence Technology on Tuesday, Dec 19, 2017 10:00 AM EST. Fluorescence-based sensing technology offers an alternative to enzyme-based, electrochemical methods of sensing. In this webinar you will learn how this technology [...]

Senseonics Advanced CGM Technology in the News

By |2017-11-16T15:54:40+00:00November 20th, 2017|CGM, Science & Technology|

The 17th Annual Diabetes Technology Meeting in Bethesda, MD earlier this month highlighted important technological and scientific advances for the management of diabetes. Senseonics Director of R&D, Dr. Andrew DeHennis was invited to participate in the panel discussion on Advances in Continuous Glucose Monitoring. As the only panel member from a company with an implantable, [...]

David Edelman visited Senseonics

By |2017-12-04T17:03:24+00:00November 14th, 2017|CGM, Senseonics|

Senseonics welcomed David Edelman from Diabetes Daily yesterday. David gave a great presentation on the importance of peer support communities for people with diabetes and their care allies. Also discussed was Senseonics’ advanced CGM technology and how it is designed to transform the CGM user experience. David talked about the importance of CGM and its [...]

What is CGM?

By |2017-12-04T16:51:24+00:00November 13th, 2016|CGM|

Continuous Glucose Monitoring, or CGM, is the process of measuring the amount of sugar (glucose) in your body every few minutes through a sensor that is placed under your skin. The continuous readings allow the system to use the data to predict the direction your glucose level is heading and will display that information as [...]